Novel Lactams as CBL-B Inhibitors for Treating Cancer.
Rachel MataPublished in: ACS medicinal chemistry letters (2023)
Provided herein are novel lactams as Cbl-b inhibitors, pharmaceutical compositions, use of such compounds in treating cancer, and processes for preparing such compounds.